US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 11.900
  • -0.740-5.85%
Close Dec 13 16:00 ET
  • 12.050
  • +0.150+1.26%
Post 20:01 ET
1.16BMarket Cap-23.80P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-13.35%-14.47M
56.33%-7.28M
46.01%-6.71M
-47.88%-59.27M
15.09%-17.41M
-124.62%-12.76M
-139.02%-16.67M
-79.48%-12.43M
-128.22%-40.08M
-20.5M
Net income from continuing operations
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
-71.33%-34.68M
---14.43M
Operating gains losses
----
----
----
----
----
----
----
----
3,600.00%140K
--143K
Depreciation and amortization
-17.28%-1.81M
-8.89%-1.89M
-10.06%-1.97M
-2,233.23%-6.81M
-683.61%-1.75M
-22,085.71%-1.54M
-4,581.08%-1.73M
-3,678.00%-1.79M
49.77%319K
--299K
Other non cash items
----
----
----
----
----
----
----
----
--1.06M
--931K
Change In working capital
178.32%2.88M
1,021.79%3.76M
7.97%2.24M
42.52%-7.33M
11.75%-10.77M
162.18%1.03M
135.04%335K
17,158.33%2.07M
-3,482.58%-12.75M
---12.2M
-Change in prepaid assets
-472.73%-504K
462.10%697K
94.83%867K
-20.99%-1.44M
-60.74%-1.92M
-163.77%-88K
155.36%124K
383.70%445K
-201.11%-1.19M
---1.19M
-Change in payables and accrued expense
286.03%4.34M
1,268.75%3.07M
-71.74%1.34M
73.00%-2.78M
22.25%-8.88M
30.85%1.12M
183.90%224K
771.06%4.76M
-1,155.95%-10.29M
---11.42M
-Change in other working capital
-1,033.33%-34K
61.54%-5K
100.80%25K
-143.10%-3.12M
-67.47%27K
98.91%-3K
97.20%-13K
-400.00%-3.13M
48.74%-1.28M
--83K
Cash from discontinued investing activities
Operating cash flow
-13.35%-14.47M
56.33%-7.28M
46.01%-6.71M
-47.88%-59.27M
15.09%-17.41M
-124.62%-12.76M
-139.02%-16.67M
-79.48%-12.43M
-128.22%-40.08M
---20.5M
Investing cash flow
Cash flow from continuing investing activities
136.06%16.82M
-128.12%-12.65M
92.37%-8.51M
-43,709.05%-87.18M
20,765.87%26.04M
-155,376.67%-46.64M
204,509.09%44.97M
-531,071.43%-111.55M
-261.82%-199K
-126K
Net PPE purchase and sale
-225.58%-140K
-26.67%-38K
56.99%-83K
12.06%-175K
172.22%91K
-43.33%-43K
-36.36%-30K
-819.05%-193K
-261.82%-199K
---126K
Net investment purchase and sale
141.76%19.46M
-128.02%-12.61M
92.43%-8.43M
---87.01M
--25.95M
---46.6M
--45M
---111.35M
--0
--0
Cash from discontinued investing activities
Investing cash flow
136.06%16.82M
-128.12%-12.65M
92.37%-8.51M
-43,709.05%-87.18M
20,765.87%26.04M
-155,376.67%-46.64M
204,509.09%44.97M
-531,071.43%-111.55M
-261.82%-199K
---126K
Financing cash flow
Cash flow from continuing financing activities
-26.17%680K
-80.90%545K
-80.44%258K
-96.38%6.9M
-99.07%1.81M
159.19%921K
558.11%2.85M
245.26%1.32M
258.80%190.73M
193.82M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
-377.77%-8.68M
---5.95M
Proceeds from stock option exercised by employees
-26.17%680K
-80.90%545K
-80.44%258K
1,110.35%6.9M
537.81%1.81M
--921K
894.43%2.85M
--1.32M
237.28%570K
--283K
Net other financing activities
----
----
----
----
----
----
----
----
--198.84M
--199.49M
Cash from discontinued financing activities
Financing cash flow
-26.17%680K
-80.90%545K
-80.44%258K
-96.38%6.9M
-99.07%1.81M
159.19%921K
558.11%2.85M
245.26%1.32M
258.80%190.73M
--193.82M
Net cash flow
Beginning cash position
-69.23%36.63M
-36.26%56.01M
-66.29%70.97M
250.50%210.52M
62.19%60.53M
166.91%119.02M
68.29%87.86M
250.50%210.52M
144.95%60.06M
--37.32M
Current changes in cash
105.18%3.03M
-162.21%-19.38M
87.80%-14.97M
-192.75%-139.55M
-93.97%10.44M
-704.69%-58.49M
508.91%31.16M
-1,461.70%-122.66M
323.32%150.46M
--173.2M
End cash Position
-34.49%39.66M
-69.23%36.63M
-36.26%56.01M
-66.29%70.97M
-66.29%70.97M
62.19%60.53M
166.91%119.02M
68.29%87.86M
250.50%210.52M
--210.52M
Free cash flow
-14.06%-14.61M
56.18%-7.32M
46.18%-6.79M
-47.58%-59.44M
16.05%-17.31M
-124.19%-12.81M
-138.69%-16.7M
-81.72%-12.62M
-128.64%-40.28M
---20.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -13.35%-14.47M56.33%-7.28M46.01%-6.71M-47.88%-59.27M15.09%-17.41M-124.62%-12.76M-139.02%-16.67M-79.48%-12.43M-128.22%-40.08M-20.5M
Net income from continuing operations -28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M-71.33%-34.68M---14.43M
Operating gains losses --------------------------------3,600.00%140K--143K
Depreciation and amortization -17.28%-1.81M-8.89%-1.89M-10.06%-1.97M-2,233.23%-6.81M-683.61%-1.75M-22,085.71%-1.54M-4,581.08%-1.73M-3,678.00%-1.79M49.77%319K--299K
Other non cash items ----------------------------------1.06M--931K
Change In working capital 178.32%2.88M1,021.79%3.76M7.97%2.24M42.52%-7.33M11.75%-10.77M162.18%1.03M135.04%335K17,158.33%2.07M-3,482.58%-12.75M---12.2M
-Change in prepaid assets -472.73%-504K462.10%697K94.83%867K-20.99%-1.44M-60.74%-1.92M-163.77%-88K155.36%124K383.70%445K-201.11%-1.19M---1.19M
-Change in payables and accrued expense 286.03%4.34M1,268.75%3.07M-71.74%1.34M73.00%-2.78M22.25%-8.88M30.85%1.12M183.90%224K771.06%4.76M-1,155.95%-10.29M---11.42M
-Change in other working capital -1,033.33%-34K61.54%-5K100.80%25K-143.10%-3.12M-67.47%27K98.91%-3K97.20%-13K-400.00%-3.13M48.74%-1.28M--83K
Cash from discontinued investing activities
Operating cash flow -13.35%-14.47M56.33%-7.28M46.01%-6.71M-47.88%-59.27M15.09%-17.41M-124.62%-12.76M-139.02%-16.67M-79.48%-12.43M-128.22%-40.08M---20.5M
Investing cash flow
Cash flow from continuing investing activities 136.06%16.82M-128.12%-12.65M92.37%-8.51M-43,709.05%-87.18M20,765.87%26.04M-155,376.67%-46.64M204,509.09%44.97M-531,071.43%-111.55M-261.82%-199K-126K
Net PPE purchase and sale -225.58%-140K-26.67%-38K56.99%-83K12.06%-175K172.22%91K-43.33%-43K-36.36%-30K-819.05%-193K-261.82%-199K---126K
Net investment purchase and sale 141.76%19.46M-128.02%-12.61M92.43%-8.43M---87.01M--25.95M---46.6M--45M---111.35M--0--0
Cash from discontinued investing activities
Investing cash flow 136.06%16.82M-128.12%-12.65M92.37%-8.51M-43,709.05%-87.18M20,765.87%26.04M-155,376.67%-46.64M204,509.09%44.97M-531,071.43%-111.55M-261.82%-199K---126K
Financing cash flow
Cash flow from continuing financing activities -26.17%680K-80.90%545K-80.44%258K-96.38%6.9M-99.07%1.81M159.19%921K558.11%2.85M245.26%1.32M258.80%190.73M193.82M
Net issuance payments of debt --------------0-----------------377.77%-8.68M---5.95M
Proceeds from stock option exercised by employees -26.17%680K-80.90%545K-80.44%258K1,110.35%6.9M537.81%1.81M--921K894.43%2.85M--1.32M237.28%570K--283K
Net other financing activities ----------------------------------198.84M--199.49M
Cash from discontinued financing activities
Financing cash flow -26.17%680K-80.90%545K-80.44%258K-96.38%6.9M-99.07%1.81M159.19%921K558.11%2.85M245.26%1.32M258.80%190.73M--193.82M
Net cash flow
Beginning cash position -69.23%36.63M-36.26%56.01M-66.29%70.97M250.50%210.52M62.19%60.53M166.91%119.02M68.29%87.86M250.50%210.52M144.95%60.06M--37.32M
Current changes in cash 105.18%3.03M-162.21%-19.38M87.80%-14.97M-192.75%-139.55M-93.97%10.44M-704.69%-58.49M508.91%31.16M-1,461.70%-122.66M323.32%150.46M--173.2M
End cash Position -34.49%39.66M-69.23%36.63M-36.26%56.01M-66.29%70.97M-66.29%70.97M62.19%60.53M166.91%119.02M68.29%87.86M250.50%210.52M--210.52M
Free cash flow -14.06%-14.61M56.18%-7.32M46.18%-6.79M-47.58%-59.44M16.05%-17.31M-124.19%-12.81M-138.69%-16.7M-81.72%-12.62M-128.64%-40.28M---20.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
US
Overall
Symbol
Price
% Chg

No Data